Literature DB >> 10052590

A novel method for determination of alpha1,6fucosyltransferase activity using a reducing oligosaccharide from egg yolk as a specific acceptor.

S Yazawa1, N Kochibe, T Nishimura, C Shima, I Takai, M Adachi, T Asao, T Hada, Y Enoki, L R Juneja.   

Abstract

A new method for determination of alpha1,6fucosyltransferase activity has been described. Recently, the disialyl-biantennary undecasaccharide was prepared in high yield from egg yolk [(1996), Carbohydr Lett 2: 137-42]. By treatment of this oligosaccharide with neuraminidase and beta-galactosidase, we readily obtained an asialo-agalacto-biantennary heptasaccharide (GlcNAcbeta 1,2Manalpha1,6[GlcNAcbeta1,2Manalpha1,3]Manbeta1 ,4GlcNAcbeta1,4GlcNAc). Using this asialo-agalacto-oligosaccharide as an acceptor, fucosyltransferases from human plasma and extracts of various human hepatoma cell lines were assayed in the presence of GDP-[3H]fucose. The reaction mixture was applied to a column of GlcNAc-binding, Psathyrella velutina lectin coupled gel. All the fucosylated acceptor were bound to the column which was eluted with 50 mM GlcNAc. Structural analyses revealed that only the innermost GlcNAc residue of the acceptor was fucosylated through an alpha1,6-linkage, and the oligosaccharide prepared could be used as a specific acceptor for alpha1,6fucosyltransferase. The present method was used to screen plasma alpha1,6fucosyltransferase in several patient groups, and significantly elevated activities were found in samples from patients with liver diseases, including chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10052590     DOI: 10.1023/a:1006954915102

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  38 in total

1.  Purification and properties of an N-acetylglucosamine-specific lectin from Psathyrella velutina mushroom.

Authors:  N Kochibe; K L Matta
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

2.  Delineation of fucosyltransferase activities with thiol reagents.

Authors:  D Kessel; T H Chou
Journal:  Biochem J       Date:  1979-09-01       Impact factor: 3.857

3.  Alpha1,3-L-fucosyltransferase expression in developing human myeloid cells. Antigenic, enzymatic, and mRNA analyses.

Authors:  J L Clarke; W Watkins
Journal:  J Biol Chem       Date:  1996-04-26       Impact factor: 5.157

Review 4.  Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.

Authors:  S Hakomori
Journal:  Cancer Res       Date:  1996-12-01       Impact factor: 12.701

5.  Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas.

Authors:  K Yamashita; K Taketa; S Nishi; K Fukushima; T Ohkura
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

6.  Carbohydrate binding specificity of immobilized Psathyrella velutina lectin.

Authors:  T Endo; H Ohbayashi; K Kanazawa; N Kochibe; A Kobata
Journal:  J Biol Chem       Date:  1992-01-15       Impact factor: 5.157

7.  Fractionation of L-fucose-containing oligosaccharides on immobilized Aleuria aurantia lectin.

Authors:  K Yamashita; N Kochibe; T Ohkura; I Ueda; A Kobata
Journal:  J Biol Chem       Date:  1985-04-25       Impact factor: 5.157

8.  Increased plasma alpha (1 --> 3)-L-fucosyltransferase activities in patients with hepatocellular carcinoma.

Authors:  T Hada; K Fukui; M Ohno; S Akamatsu; S Yazawa; K Enomoto; K Yamaguchi; Y Matsuda; Y Amuro; N Yamanaka
Journal:  Glycoconj J       Date:  1995-10       Impact factor: 2.916

9.  Genetic and enzymatic evidence for Lewis enzyme expression in Lewis-negative cancer patients.

Authors:  S Yazawa; S Nishihara; H Iwasaki; T Asao; Y Nagamachi; K L Matta; H Narimatsu
Journal:  Cancer Res       Date:  1995-04-01       Impact factor: 12.701

10.  Aberrant alpha 1-->2fucosyltransferases found in human colorectal carcinoma involved in the accumulation of Leb and Y antigens in colorectal tumors.

Authors:  S Yazawa; J Nakamura; T Asao; Y Nagamachi; M Sagi; K L Matta; T Tachikawa; M Akamatsu
Journal:  Jpn J Cancer Res       Date:  1993-09
View more
  1 in total

1.  Fucosylated Glycans in α1-Acid Glycoprotein for Monitoring Treatment Outcomes and Prognosis of Cancer Patients.

Authors:  Shin Yazawa; Ryo Takahashi; Takehiko Yokobori; Rie Sano; Akira Mogi; Abby R Saniabadi; Hiroyuki Kuwano; Takayuki Asao
Journal:  PLoS One       Date:  2016-06-13       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.